Features
Screener
Pricing
Resources
About
en
Features
Screener
Pricing
Resources
About
Language
en
Login
Start for free
DISCOVER
Screener
Stocks
ETF
Crypto
SCPI
Trending
Comparator
Calendar
Charting
Super investors
SOCIAL
Community
Public portfolios
/
Image Modal
Image Modal Description
Harbin Medisan Pharmaceutical Co., Ltd.
002900.SZ
-
CNE1000032V9
Compare
Last update : Aug 21, 2026 at 23:35
General
Scores
Financials
Ratios
Valuation
Dividend
Exposure
Analysts
Insider
Harbin Medisan Pharmaceutical Co., Ltd. (002900.SZ) Dividend, Growth and Profitability Scores - Invvest
Dividend
Last update : Jul 31, 2026
2
Xwt
Metrics
Value
Rating
Payout ratio
59
4vWYh
5ERNq
Free cash flow payout ratio
73
Urzwx
Dh2Mm
3Y Earnings growth
66
Z797S
gTN3i
Dividend streak
43
LlxX2
11UqG
Dividend growth streak
88
8yV8F
8elO5
5Y Dividend growth
69
pWEKn
ZNDKd
15Y Dividend cut
73
9mfLp
By1Tr
15Y Dividend interruption
35
NZrWn
P9DR7
Return on equity
27
bbxaA
EIp0P
Net debt / EBITDA
96
6x7k1
SgGkD
Interest coverage
14
Mve9K
aKYzT
Growth
Last update : Jul 30, 2026
13
Y15RB5ty
Metrics
Value
Rating
Revenue growth
82
Lz7Z8
brw1C
5Y Revenue growth
98
XgEeT
KJvbE
EBITDA growth
92
qrt6S
Financial Strength
Last update : Jul 30, 2026
15
OX7Xr
Metrics
Value
Rating
Interest coverage
6
HEhqS
XpOZi
Quick ratio
13
NAcHG
ET3f1
Debt / Assets
81
pzSBg
Profitability
Last update : Jul 30, 2026
2
Qu8q6n
Metrics
Value
Rating
Gross margin
1
RGgBd
BWOwg
Operating margin
55
ctZ3q
q38Px
Net margin
54
sbu58
KFoAN
Momentum
Last update : Aug 23, 2026
2
Ib1FU
Metrics
ESG
No data available currently
Piotroski F
Last update : Aug 4, 2026
6
Unlock this feature
0
3
6
9
Altman Z
Last update : Aug 4, 2026
1
Unlock this feature
0 and -
1.8
3
4.5 and +
KdtET
5Y EBITDA growth
10
f4tDe
rb3ie
Operating income growth
3
8zPFl
tl4l3
5Y Operating income growth
89
EfMeZ
HI9Pe
Free cash flow growth
92
O46Lv
t1DNz
5Y Free cash flow growth
31
1WDZ3
lSkNA
Operating cash flow growth
30
jPk65
rWjGg
5Y Operating cash flow growth
33
2r1sg
VQrGM
Capex growth
88
st7gj
9fZWy
zeIOX
Debt / Equity
71
GAigX
YiPU6
Net debt / EBITDA
12
0mH7r
IuNVp
Cash / Debt
36
lzrSg
tiDKS
Altman Z Score
14
wYeiW
NpY9Y
Piotroski F Score
12
UrTpO
w2xwi
Capex coverage ratio
91
twk9e
phinF
Free cash flow margin
27
vzeTL
Tl3LN
Return on invested capital
46
kyVMB
camvc
Return on equity
32
jYmf5
6KToJ
Return on assets
79
48p4f
5vQ4J
Capex / Revenue
38
rZ6rB
vcxHh
Profitable years 5Y
20
bDuCN
I6sxl
Value
Rating
SMA 50 vs Price
24
ft0kE
Oq4EA
SMA 200 vs Price
84
epOKK
1MSD9
SMA 50 vs SMA 200
59
v8X7j
n30Wz
1M Decile rank
90
DFKin
8v0op
6M Decile rank
70
LccwN
6VG3d
1Y Decile rank
89
5rFn6
nPk50
